The HS Scientific Strategy Lead will lead the commercial scientific strategy for the company's investigational monoclonal antibody tulisokibart in hidradenitis suppurativa (HS). Following positive Phase 2b results, the program is advancing toward Phase 3 and global launch readiness. The role translates complex science, clinical evidence and customer insight into a clear, differentiated and credible scientific narrative, while supporting the global commercial ambition, Phase 3 program and launch readiness. Working at the intersection of Commercial, Medical Affairs, Clinical Development, Outcomes Research, Global Market Access, Policy and priority markets, the role identifies evidence needs and supports scientific engagement and evidence planning. It also contributes to early Dermatology pipeline and business development assessments. This position reports to the Executive Director, Global Commercial Lead, Hidradenitis Suppurativa. The primary location is Rahway, New Jersey, and the role has a hybrid work arrangement and 25% travel requirement.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director